To investigate the effect of KLF9 overexpression or knockdown on cell proliferation and to study the response of paclitaxel’s anti-proliferative effects in malignant melanoma cells, we stained RPMI-7951 and A375 cells with the nuclear proliferation marker (Ki67). Here, MKI67 is linked to melanoma.